Bell Rock Capital LLC Abbott Laboratories Transaction History

Bell Rock Capital LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 07, 2020	SELL	$62.82 - $91.86 $44,225 - $64,669	-704 Closed	0 $0
Q4 2019 Feb 03, 2020	SELL	$78.51 - $87.4 $942 - $1,048	-12 Reduced 1.68%	704 $61,000
Q3 2019 Nov 07, 2019	BUY	$81.84 - $88.74 $16,531 - $17,925	202 Added 39.3%	716 $60,000
Q2 2019 Jul 31, 2019	BUY	$72.88 - $85.0 $36,440 - $42,500	500 Added 3571.43%	514 $0
Q4 2018 Jan 25, 2019	SELL	$65.56 - $74.27 $74,082 - $83,925	-1,130 Reduced 98.78%	14 $1,000
Q1 2018 Nov 14, 2018	SELL	$56.27 - $63.62 $58,014 - $65,592	-1,031 Reduced 47.4%	1,144 $69,000
Q3 2017 Dec 06, 2018	BUY	$48.06 - $53.64 $54,980 - $61,364	1,144 Added 110.96%	2,175 $116,000
Q4 2016 Dec 05, 2018	BUY	N/A	1,031	1,031 $40,000

3,208

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $224B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Bell Rock Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Bell Rock Capital LLC with notifications on news.